Authors: MYLOTTE JM RODGERS J FASSL M SEIBEL K VACANTI A

Citation: Jm. Mylotte et al., DERIVATION AND VALIDATION OF A PULMONARY TUBERCULOSIS PREDICTION MODEL, Infection control and hospital epidemiology, 18(8), 1997, pp. 554-560

Authors: KIRCHGESSNER M SCHLIACK M SPAULDING G EDER K LOSER R SEIBEL K ERHARDT W ASCHERL R

Citation: M. Kirchgessner et al., THE EFFECT OF THE HYPOLIPIDEMIC COMPOUND LIFIBROL ON BILE-FLOW, BILE LIPIDS AND THE LITHOGENIC INDEX OF BILE IN PIGS, Journal of animal physiology and animal nutrition, 71(4-5), 1994, pp. 261-267

Authors: KIRCHGESSNER M SCHLIACK M SPAULDING G LOSER R SEIBEL K EDER K ERHARDT W ASCHERL R

Citation: M. Kirchgessner et al., INFLUENCE OF THE HYPOCHOLESTEROLEMIC COMPOUND LIFIBROL ON SERUM-LIPIDS AND ON PARAMETERS OF CLINICAL-CHEMISTRY AND HEMATOLOGY OF PIGS, Journal of animal physiology and animal nutrition, 71(4-5), 1994, pp. 268-276

Authors: HASMANN M LOSER R KOHR A SEIBEL K

Citation: M. Hasmann et al., INHIBITION OF HUMAN TUMOR-CELL GROWTH WIT H INTERMITTENT DROLOXIFENE TREATMENTS, Onkologie, 17, 1994, pp. 22-26

Authors: SCHWANDT P ELSASSER R SCHMIDT C GERTZ B HEIL M AUGUSTIN J SEIBEL K

Citation: P. Schwandt et al., SAFETY AND EFFICACY OF LIFIBROL UPON 4-WEEK ADMINISTRATION TO PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, European Journal of Clinical Pharmacology, 47(2), 1994, pp. 133-138